Steven Immergut | Head of Communications and IR |
Ted Love | President and CEO |
Jeff Farrow | CFO |
David Johnson | Chief Commercial Officer |
Alethia Young | Cantor Fitzgerald |
Jim Birchenough | Wells Fargo |
Yatin Suneja | Guggenheim Partners |
Lyla Youssef | Cowen & Company |
Paul Choi | Goldman Sachs |
Matthew Holt | J.P. Morgan |
Andreas Argyrides | Wedbush Securities |
Jason Gerberry | Bank of America Merrill Lynch |
Benjamin Burnett | Stifel Nicolaus |
Elemer Piros | ROTH Capital Partners |
John Newman | Canaccord Genuity |
Danielle Brill | Raymond James |
Greetings, and welcome to the Global Blood Therapeutics' Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the call over to Steven Immergut. Please go ahead.